Medifast (MED) Operating Income (2010 - 2026)

Medifast (MED) has 17 years of Operating Income data on file, last reported at -$3.3 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Income fell 161.09% year-over-year to -$3.3 million; the trailing twelve-month figure through Mar 2026 stood at -$16.2 million (down 156.92% YoY), and the FY2025 full-year result was -$14.2 million, down 593.85% from the prior year.
• Operating Income for Q1 2026 stood at -$3.3 million, up from -$7.8 million in the prior quarter.
• Across five years, Operating Income topped out at $55.1 million in Q1 2022 and bottomed at -$7.9 million in Q2 2024.
• The 5-year median for Operating Income is $7.9 million (2024), against an average of $17.4 million.
• Peak annual rise in Operating Income reached 86.47% in 2025, while the deepest fall reached 1200.56% in 2025.
• A 5-year view of Operating Income shows it stood at $32.6 million in 2022, then sank by 73.39% to $8.7 million in 2023, then slumped by 91.83% to $709000.0 in 2024, then plunged by 1200.56% to -$7.8 million in 2025, then jumped by 57.77% to -$3.3 million in 2026.
• The last three Operating Income figures came in at -$3.3 million (Q1 2026), -$7.8 million (Q4 2025), and -$4.1 million (Q3 2025), per Business Quant data.

Peer Comparison